cabergoline has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arenas, C; Battellino, M; Caney, S; Corsini, A; Fleeman, LM; Fracassi, F; Leal, RO; Miceli, DD; Niessen, SJ; Sieber-Ruckstuhl, NS; Zeugswetter, FK | 1 |
| Ahlskog, JE; Kokmen, E; Low, PA; Nickander, KK; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
2 other study(ies) available for cabergoline and Diabetes Mellitus
| Article | Year |
|---|---|
Quality of life and response to treatment in cats with hypersomatotropism: the owners' point of view.
Topics: Acromegaly; Animals; Cabergoline; Cat Diseases; Cats; Diabetes Mellitus; Quality of Life; Surveys and Questionnaires | 2022 |
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Brain; Cabergoline; Carbidopa; Diabetes Mellitus; Ergolines; Female; Free Radicals; Humans; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Selegiline; Vitamin E | 1995 |